Inhibitor Therapeutics, Inc. (INTI) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2012: $1.07M2013: $776.1K2014: $400.9K2015: $461.9K2016: $308.1K2017: $601.5K2018: $1.20M2019: $3.43M2020: $3.49M2021: $3.68M2022: $3.68M2023: $3.67M2024: $3.71M2025: $3.80M$3.80M
2012Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$3.80M+2.5%
2024$3.71M+1.2%
2023$3.67M-0.4%
2022$3.68M-0.0%
2021$3.68M+5.4%
2020$3.49M+1.8%
2019$3.43M+185.8%
2018$1.20M+99.6%
2017$601.5K+95.2%
2016$308.1K-33.3%
2015$461.9K+15.2%
2014$400.9K-48.3%
2013$776.1K-27.4%
2012$1.07M